New player in CAR-T manufacture field: comparison of umbilical cord to peripheral blood strategies
One of the most successful treatments in hematologic cancer is chimeric antigen receptor (CAR)-T cell-based immunotherapy. However, CAR-T therapy is not without challenges like the costly manufacturing process required to personalize each treatment for…